Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$778M |
| 2 |
Walt Disney
DIS
|
+$575M |
| 3 |
Amazon
AMZN
|
+$558M |
| 4 |
Applied Materials
AMAT
|
+$373M |
| 5 |
eBay
EBAY
|
+$349M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$669M |
| 2 |
Philip Morris
PM
|
+$454M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 4 |
Marvell Technology
MRVL
|
+$371M |
| 5 |
Qualcomm
QCOM
|
+$325M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.2% |
| 2 | Financials | 10.85% |
| 3 | Healthcare | 9.88% |
| 4 | Industrials | 8.88% |
| 5 | Consumer Discretionary | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3676
ALX Oncology
ALXO
$266M
| $129K | ﹤0.01% |
+11,535
| New | +$162K |
|
|
MAXN
3677
DELISTED
Maxeon Solar Technologies
MAXN
| $128K | ﹤0.01% |
383
+1
| +0.3% | +$450 |
|
|
MHN
3678
DELISTED
BlackRock MuniHoldings New Yrok Quality Fund
MHN
| $126K | ﹤0.01% |
11,917
-1,768
| -13% | -$18.7K |
|
3679
Ecopetrol
EC
$33.6B
| $126K | ﹤0.01% |
10,627
-657
| -6% | -$7.61K |
|
|
VLRS
3680
Controladora Vuela Compania de Aviacion
VLRS
$960M
| $125K | ﹤0.01% |
16,906
+2,125
| +14% | +$16.4K |
|
3681
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$898M
| $124K | ﹤0.01% |
11,427
-44,463
| -80% | -$478K |
|
|
JMIA
3682
Jumia Technologies
JMIA
$763M
| $124K | ﹤0.01% |
24,200
-378
| -2% | -$1.69K |
|
|
PVBC
3683
DELISTED
Provident Bancorp
PVBC
| $124K | ﹤0.01% |
13,584
-1,350
| -9% | -$13.5K |
|
3684
Opko Health
OPK
$985M
| $124K | ﹤0.01% |
102,991
-7,700
| -7% | -$7.71K |
|
|
VTYX
3685
DELISTED
Ventyx Biosciences
VTYX
| $122K | ﹤0.01% |
+22,253
| New | +$102K |
|
3686
First Majestic Silver
AG
$8.05B
| $122K | ﹤0.01% |
20,741
+1,928
| +10% | +$9.66K |
|
3687
1stdibs.com
DIBS
$152M
| $122K | ﹤0.01% |
20,423
| – | – |
|
3688
Sana Biotechnology
SANA
$910M
| $121K | ﹤0.01% |
+12,115
| New | +$90.8K |
|
3689
Cornerstone Strategic Value Fund
CLM
$2.22B
| $120K | ﹤0.01% |
+16,171
| New | +$115K |
|
3690
Pacific Biosciences
PACB
$447M
| $118K | ﹤0.01% |
31,410
-1,042,745
| -97% | -$6.11M |
|
|
TSVT
3691
DELISTED
2seventy bio
TSVT
| $117K | ﹤0.01% |
21,938
-21,829
| -50% | -$103K |
|
|
CGAU
3692
Centerra Gold
CGAU
$3.53B
| $117K | ﹤0.01% |
19,810
+3,440
| +21% | +$18.6K |
|
3693
Garrett Motion
GTX
$5.74B
| $117K | ﹤0.01% |
11,759
-1,964
| -14% | -$18.1K |
|
|
MRNS
3694
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $116K | ﹤0.01% |
+12,781
| New | +$124K |
|
|
DRD
3695
DRDGold
DRD
$1.86B
| $115K | ﹤0.01% |
+14,055
| New | +$107K |
|
|
CRF
3696
Cornerstone Total Return Fund
CRF
$1.16B
| $112K | ﹤0.01% |
+15,151
| New | +$107K |
|
3697
AMC Entertainment Holdings
AMC
$2.45B
| $111K | ﹤0.01% |
+29,817
| New | +$133K |
|
3698
Perspective Therapeutics
CATX
$344M
| $111K | ﹤0.01% |
9,320
+7,820
| +521% | +$66.7K |
|
3699
Community Health Systems
CYH
$408M
| $111K | ﹤0.01% |
31,678
+4,928
| +18% | +$16.7K |
|
|
CIM
3700
Chimera Investment
CIM
$1.05B
| $111K | ﹤0.01% |
8,005
-2,771
| -26% | -$38.6K |
|
Similar funds
Ameriprise's Q1 2024 Portfolio in Review
As of Q1 2024, Ameriprise held 4,016 positions worth $363B, up 8.8% from $334B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Ameriprise's Q1 2024 filing shows 118 new, 1,585 increased, 2,002 reduced and 175 closed positions. Its largest new stake was Arcadium Lithium plc: 13,685,562 shares worth $59M. The largest sale was Lam Research, an estimated $669M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q1 2024 buy was Arcadium Lithium plc: 13,685,562 shares worth $59M.
- Ameriprise added most to Meta Platforms (Facebook) in Q1 2024, an estimated $778M increase.
- Ameriprise's biggest Q1 2024 reduction was Lam Research, cutting an estimated $669M.
- Ameriprise fully exited Livent Corporation in Q1 2024, selling an estimated $120M.
- Ameriprise's ten largest holdings make up 18% of its $363B portfolio in Q1 2024.
- Ameriprise opened 118 new positions and closed 175 in Q1 2024.
- Ameriprise's portfolio value rose 8.8% quarter-over-quarter to $363B.
Based on Ameriprise's 13F filing for Q1 2024, filed 15 May 2024.